Boston Millennia Partners

Boston Millennia Partners is an investment firm based in Massachusetts, incorporated in 1984, with a focus on growth capital investing across the United States. The firm specializes in providing equity financing to high-growth companies, particularly in the healthcare and business services sectors, including outsourcing and software as a service businesses. Boston Millennia Partners aims to build enduring, large-scale enterprises through active participation and supportive partnerships with entrepreneurs who are committed to achieving substantial financial returns. With a strong emphasis on creating long-term value, the firm leverages its extensive network and industry expertise to identify and nurture investment opportunities. Its recent funds target sectors such as information technology, healthcare, and digital health, reflecting the firm's strategic focus on innovative industries.

Elizabeth Callow

Senior Associate

Allan Dana Callow

Founder and Managing Partner

Dana Callow Jr.

Founder & Managing Partner

Walter M. Capone

Venture Partner

Jessica Federer

Venture Affiliate Partner

Patrick J. Fortune

Operating Partner

Martin J. Hernon

General Partner

Marty Hernon

General Partner

Amy Merk

Director of Administration and Investor Relations

Alex D. Ray

Associate

Ren Roome

Senior Associate

Frank Silva

Principal

Bruce Tiedemann

CFO

128 past transactions

KAID Health

Series A in 2022
KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve.

Huma.AI

Series A in 2022
Huma.AI, Inc. is a technology company based in Palo Alto, California, that focuses on knowledge automation for the pharmaceutical and healthcare industries. Incorporated in 2016, Huma.AI addresses inefficiencies caused by complex and disconnected systems that hinder data accessibility and insights. The company's platform connects disparate data silos through natural language processing, enabling users to easily access information and gain actionable insights without requiring specialized technical knowledge. By simplifying interactions with data, Huma.AI aims to enhance decision-making and operational efficiency in a sector characterized by an overwhelming volume of information.

Reveleer

Venture Round in 2021
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.

BEKHealth

Seed Round in 2021
Developer of clinical research software designed to accelerate timelines by automating multiple impact processes. The company's software provides complete rapid trial feasibility, electronic medical record data processing, feasibility and site selection, precision patient trial matching and care coordination, enabling clients to reduce cost increase enrollment and streamline the clinical research process.

Clinical Research IO

Series A in 2021
Clinical Research IO is a health technology company that specializes in developing software for clinical research sites. The company offers an electronic source (eSource) platform that allows research investigators to create customizable templates for capturing clinical trial data using mobile devices, thereby enhancing efficiency and accuracy in the data collection process. The software includes modules for patient recruitment, scheduling, and compliance management, which feature tools for sending text reminders to patients. Additionally, Clinical Research IO integrates its eSource with a Clinical Trial Management System (CTMS) that facilitates the management of regulatory documents electronically. With offices in Boston and San Francisco, the company aims to modernize the traditionally paper-based clinical trial process.

Turbine

Seed Round in 2021
Turbine Ltd is a biotechnology company based in Budapest, Hungary, founded in 2015. It specializes in the development of computational models that predict biological and clinical outcomes to aid in cancer drug development. Utilizing its proprietary Simulated Cell technology alongside artificial intelligence, Turbine focuses on understanding the intricate mechanisms of cancer. This approach facilitates the discovery of novel protein targets and precision biomarkers, enhancing the translation of research to patient care. The company also creates cancer combination therapies that clarify the underlying biology of diseases and personalize treatment options. By leveraging bioinformatics and network medicine, Turbine effectively simulates complex interventions, allowing for the screening of numerous drug combinations on simulated cells. This innovative process aims to provide cancer patients with low-cost and effective treatment plans.

SomaLogic

Series A in 2020
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

COTA, Inc.

Series D in 2020
COTA, Inc. is a Boston-based company founded in 2011 by a team of doctors, engineers, and data scientists. It develops a platform that focuses on improving cancer care through the collection and analysis of real-world data. COTA's services include data curation and oncology analytics, which assist healthcare providers and cancer centers in managing fragmented electronic health record (EHR) data. The platform enables clinicians and researchers to gain insights into patient populations, treatment patterns, and disease outcomes, thereby enhancing decision-making in cancer treatment. Furthermore, COTA identifies variations in care and supports the design of innovative care models, such as bundled payments and shared-risk arrangements. Its clientele includes healthcare providers, payers, life sciences companies, patients, and regulatory bodies like the FDA.

Fit4D

Series B in 2020
Cecelia Health is tech-enabled diabetes and chronic disease management company that combines technology with expert clinical coaching. It aims to transform the lives and health outcomes of people with diabetes, obesity, cardiovascular disease, and other chronic conditions. Cecelia Health helps people with chronic conditions adhere to their medications and related nutrition, health, and wellness programs. During COVID-19, Cecelia Health has also been offering telehealth support to patients. It was founded in 2009 and headquartered in New York, United States.

CareAlign

Seed Round in 2020
TrekIT provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.

Reveleer

Series C in 2020
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control over their risk adjustment and quality improvement programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction and reporting – all under one single platform. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.

Health Decisions

Venture Round in 2020
Health Decisions, Inc. provides clinical research services. It offers project management, medical writing, data management, biostatistics, quality management, and regulatory compliance services. The company also provides strategic consulting and clinical services. Health Decisions, Inc. was founded in 1989 and is headquartered in Durham, North Carolina.

iQuartic

Venture Round in 2020
iQuartic, Inc. specializes in developing cloud platforms aimed at data networking and mining within the healthcare sector. The company's technology facilitates essential functions such as EHR and claims auditing, quality benchmarking, population health management, disease management, risk profiling, and revenue optimization. Key offerings include the iQ EHR Network, which integrates disparate EMR systems across various facilities; iQ EHR Auditing, which utilizes advanced analytics to identify inconsistencies in EHR data; and iQ ACO Software, designed for accountable care organizations to analyze networks and patient data comprehensively. Additional products encompass predictive modeling tools like the EHR Data Auditor, which focuses on HIV patient reporting; the Diabetes Management Scorecard; and the COPD Population Profiler, among others. These tools aim to enhance chronic disease management, predict hospital readmissions, and improve clinician profiling. Founded in 2012, iQuartic is headquartered in Boston, Massachusetts.

Forefront TeleCare

Series A in 2019
Forefront TeleCare, Inc. is a pioneer and U.S. leader in the delivery of behavioral health services to small, rural healthcare facilities via our unique HIPAA-compliant TeleCare service which incorporates software, hardware, and comprehensive service protocols. Our current specialty services include psychiatry and clinical psychology, and we expect to begin delivering both physiatry and advanced wound care services by early 2014. Our client facilities include skilled nursing facilities and clinics in 18 states from coast to coast. Our Forefront Provider Network currently includes psychiatrists, clinical psychologists, and psychiatric nurse practitioners.

Roobrik

Venture Round in 2018
Roobrik, Inc. is an online platform founded in 2013 and based in Greensboro, North Carolina. The company specializes in providing decision-making tools designed to assist caregivers, senior care providers, and clinicians in navigating health and care choices. By offering resources that empower older adults and their families, Roobrik facilitates informed decision-making and helps users connect with various products, services, and programs to meet their needs.

COTA, Inc.

Series C in 2018
COTA, Inc. is a Boston-based company founded in 2011 by a team of doctors, engineers, and data scientists. It develops a platform that focuses on improving cancer care through the collection and analysis of real-world data. COTA's services include data curation and oncology analytics, which assist healthcare providers and cancer centers in managing fragmented electronic health record (EHR) data. The platform enables clinicians and researchers to gain insights into patient populations, treatment patterns, and disease outcomes, thereby enhancing decision-making in cancer treatment. Furthermore, COTA identifies variations in care and supports the design of innovative care models, such as bundled payments and shared-risk arrangements. Its clientele includes healthcare providers, payers, life sciences companies, patients, and regulatory bodies like the FDA.

Mingle Health

Venture Round in 2018
Mingle Health is a company focused on Transforming healthcare through data-driven solutions.

C2Sense

Seed Round in 2017
C2Sense, Inc. develops chemiresistive gas sensors for food and agriculture applications. Its sensors are used to detect ethylene, biogenic amines, and other relevant gases at low parts per million (ppm) and sub-ppm concentrations; and monitor fruit ripeness and meat/fish/poultry freshness at all stages of the supply chain. The company’s sensors help to improve food quality and address the problem of waste by allowing growers, shippers, distributors, retailers, and consumers to make decisions to reduce waste at every stage. C2Sense, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

Bivarus

Series B in 2017
Bivarus, Inc. is a company based in Durham, North Carolina, specializing in a cloud-based analytics platform designed to enhance continuous quality improvement (CQI) and the patient experience within hospital-based outpatient services, community clinics, and group practices. Founded in 2010, Bivarus emerged from academic research that highlighted the significance of patient experience as a predictor of health outcomes. The platform provides healthcare leaders with actionable insights into the factors influencing patient experience, provider performance, and service operations, enabling real-time identification of service issues and evaluation of quality improvement initiatives. Bivarus is recognized as a CMS-approved CAHPS® partner and also offers services for assessing employee perceptions related to organizational effectiveness, culture, and safety, thereby supporting engagement across healthcare organizations. As of January 2018, Bivarus operates as a subsidiary of Press Ganey Holdings, Inc.

COTA, Inc.

Series B in 2016
COTA, Inc. is a Boston-based company founded in 2011 by a team of doctors, engineers, and data scientists. It develops a platform that focuses on improving cancer care through the collection and analysis of real-world data. COTA's services include data curation and oncology analytics, which assist healthcare providers and cancer centers in managing fragmented electronic health record (EHR) data. The platform enables clinicians and researchers to gain insights into patient populations, treatment patterns, and disease outcomes, thereby enhancing decision-making in cancer treatment. Furthermore, COTA identifies variations in care and supports the design of innovative care models, such as bundled payments and shared-risk arrangements. Its clientele includes healthcare providers, payers, life sciences companies, patients, and regulatory bodies like the FDA.

BC Platforms

Venture Round in 2016
BC Platforms specializes in genomic data management solutions that aim to tackle significant healthcare challenges through the integration of genomics and information technology. The company's platform facilitates the flexible integration, secure analysis, and interpretation of molecular and clinical big data in a systematic and standardized manner. By providing robust tools for managing genomic data, BC Platforms supports researchers and healthcare professionals in deriving meaningful insights to advance precision medicine and improve patient outcomes.

Bivarus

Series A in 2016
Bivarus, Inc. is a company based in Durham, North Carolina, specializing in a cloud-based analytics platform designed to enhance continuous quality improvement (CQI) and the patient experience within hospital-based outpatient services, community clinics, and group practices. Founded in 2010, Bivarus emerged from academic research that highlighted the significance of patient experience as a predictor of health outcomes. The platform provides healthcare leaders with actionable insights into the factors influencing patient experience, provider performance, and service operations, enabling real-time identification of service issues and evaluation of quality improvement initiatives. Bivarus is recognized as a CMS-approved CAHPS® partner and also offers services for assessing employee perceptions related to organizational effectiveness, culture, and safety, thereby supporting engagement across healthcare organizations. As of January 2018, Bivarus operates as a subsidiary of Press Ganey Holdings, Inc.

Collegium Pharmaceutical

Venture Round in 2015
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating patients suffering from pain, particularly in relation to opioid medications. The company utilizes its proprietary DETERx platform technology, which enhances the safety and extended-release properties of medications while minimizing the risk of misuse through methods such as chewing, crushing, and injecting. Among its key offerings is Xtampza ER, an abuse-deterrent, extended-release formulation of oxycodone, alongside Nucynta ER and Nucynta IR, which are formulations of tapentadol designed for managing severe and moderate to severe pain, respectively. Collegium focuses on addressing the challenges related to the non-medical use of prescription drugs by emphasizing tamper-resistant features and innovative delivery systems in its product portfolio. Founded in 2002 and based in Stoughton, Massachusetts, the company aims to provide effective pain management solutions while prioritizing patient safety.

G-Form

Venture Round in 2015
G-Form, LLC is a manufacturer of protective gear for athletic and consumer electronic applications, established in 2010 and headquartered in Providence, Rhode Island. The company's product lineup includes protective equipment for various sports, such as knee, elbow, and shin pads, as well as specialized items like shorts, brake hood overgrips, and saddle gel kits. Additionally, G-Form produces protective solutions for electronic devices, including gear for laptops, iPads, iPhones, and tablets. The company distributes its products through a network of retailers and distributors both domestically and internationally, in addition to offering online sales within the United States. G-Form is recognized for its commitment to creating protective and comfortable athletic equipment.

Avhana Health

Seed Round in 2014
Avhana Health Inc. provides an application to simplify the healthcare provider workflow by offering the latest guidelines, actionable recommendations, and performance metrics—directly in their EHR. Its application features a dashboard for pre-visit planning, patient-specific recommendations for care, corresponding order suggestions that submit to the EHR, and a dashboard for tracking provider activity and performance. The company was founded in 2014 and is based in Baltimore, Maryland.

Odyssey Logistics & Technology

Venture Round in 2014
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Odyssey Logistics & Technology

Venture Round in 2014
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

PreCision Dermatology

Debt Financing in 2013
PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.

Histogenics

Series C in 2012
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Collegium Pharmaceutical

Venture Round in 2012
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating patients suffering from pain, particularly in relation to opioid medications. The company utilizes its proprietary DETERx platform technology, which enhances the safety and extended-release properties of medications while minimizing the risk of misuse through methods such as chewing, crushing, and injecting. Among its key offerings is Xtampza ER, an abuse-deterrent, extended-release formulation of oxycodone, alongside Nucynta ER and Nucynta IR, which are formulations of tapentadol designed for managing severe and moderate to severe pain, respectively. Collegium focuses on addressing the challenges related to the non-medical use of prescription drugs by emphasizing tamper-resistant features and innovative delivery systems in its product portfolio. Founded in 2002 and based in Stoughton, Massachusetts, the company aims to provide effective pain management solutions while prioritizing patient safety.

NuVox

Venture Round in 2012
Windstream Communications provides voice and data network communications, and managed services to businesses in the United States.

Odyssey Logistics & Technology

Venture Round in 2010
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

SensorLogic

Venture Round in 2010
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.

Nexidia

Series F in 2010
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.

CardioMEMS

Venture Round in 2010
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Coapt Systems

Debt Financing in 2009
Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

CardioMEMS

Series F in 2009
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

MedAptus

Venture Round in 2009
MedAptus, Inc. specializes in developing clinical workforce and workflow solutions that enhance charge capture and operational management for healthcare providers. The company offers a variety of products tailored to different healthcare settings, including Pro Charge Capture for hospitalist groups and multi-specialty clinics, and various editions designed for specific needs, such as the Inpatient Edition for hospitalists and the Facility Edition for outpatient clinics. These solutions aim to streamline patient management tasks, improve charge capture efficiency, and reduce administrative burdens. Additionally, MedAptus provides cloud-based tools like Assign for Rounding Providers, which optimizes daily patient assignments, and MedAptus Collaborate, which facilitates secure communication among care teams. The company serves a diverse clientele, including hospitals, health systems, group practices, and academic medical centers. Founded in 1999 and based in Boston, Massachusetts, MedAptus operates as a subsidiary of Volaris Group Inc.

Histogenics

Series B in 2008
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Collegium Pharmaceutical

Series D in 2008
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating patients suffering from pain, particularly in relation to opioid medications. The company utilizes its proprietary DETERx platform technology, which enhances the safety and extended-release properties of medications while minimizing the risk of misuse through methods such as chewing, crushing, and injecting. Among its key offerings is Xtampza ER, an abuse-deterrent, extended-release formulation of oxycodone, alongside Nucynta ER and Nucynta IR, which are formulations of tapentadol designed for managing severe and moderate to severe pain, respectively. Collegium focuses on addressing the challenges related to the non-medical use of prescription drugs by emphasizing tamper-resistant features and innovative delivery systems in its product portfolio. Founded in 2002 and based in Stoughton, Massachusetts, the company aims to provide effective pain management solutions while prioritizing patient safety.

SensorLogic

Series C in 2008
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.

Arthrosurface

Series F in 2008
Arthrosurface, Inc. operates as an orthopedic medical device company that designs and manufactures minimally invasive joint resurfacing systems. The company offers surface implant curvatures for knee, shoulder and wrist, hip, foot and ankle, and toe. Its surface implant curvatures are designed to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease. The company serves patients and surgeons through a network of sales representatives or distributors in the United States and internationally. Arthrosurface, Inc. was incorporated in 2001 and is based in Franklin, Massachusetts. As of February 3, 2020, Arthrosurface, Inc. operates as a subsidiary of Anika Therapeutics, Inc.

MedAptus

Venture Round in 2007
MedAptus, Inc. specializes in developing clinical workforce and workflow solutions that enhance charge capture and operational management for healthcare providers. The company offers a variety of products tailored to different healthcare settings, including Pro Charge Capture for hospitalist groups and multi-specialty clinics, and various editions designed for specific needs, such as the Inpatient Edition for hospitalists and the Facility Edition for outpatient clinics. These solutions aim to streamline patient management tasks, improve charge capture efficiency, and reduce administrative burdens. Additionally, MedAptus provides cloud-based tools like Assign for Rounding Providers, which optimizes daily patient assignments, and MedAptus Collaborate, which facilitates secure communication among care teams. The company serves a diverse clientele, including hospitals, health systems, group practices, and academic medical centers. Founded in 1999 and based in Boston, Massachusetts, MedAptus operates as a subsidiary of Volaris Group Inc.

CardioMEMS

Series E in 2007
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Infotrieve

Series C in 2007
Information management company providing consultation and business service solutions for information centers

Arthrosurface

Series F in 2007
Arthrosurface, Inc. operates as an orthopedic medical device company that designs and manufactures minimally invasive joint resurfacing systems. The company offers surface implant curvatures for knee, shoulder and wrist, hip, foot and ankle, and toe. Its surface implant curvatures are designed to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease. The company serves patients and surgeons through a network of sales representatives or distributors in the United States and internationally. Arthrosurface, Inc. was incorporated in 2001 and is based in Franklin, Massachusetts. As of February 3, 2020, Arthrosurface, Inc. operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Xconomy

Series A in 2007
Xconomy is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. We are the authoritative voice on the exponential economy, the realm of business and innovation characterized by exponential technological growth and responsible for an increasing share of productivity and overall economic growth. We deliver this valuable content through a unique global network of localized news sites, events, conferences, and other initiatives designed to better connect people and ideas.

SensorLogic

Series B in 2007
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.

Coapt Systems

Series E in 2007
Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

CardioMEMS

Series D in 2006
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Collegium Pharmaceutical

Series C in 2006
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating patients suffering from pain, particularly in relation to opioid medications. The company utilizes its proprietary DETERx platform technology, which enhances the safety and extended-release properties of medications while minimizing the risk of misuse through methods such as chewing, crushing, and injecting. Among its key offerings is Xtampza ER, an abuse-deterrent, extended-release formulation of oxycodone, alongside Nucynta ER and Nucynta IR, which are formulations of tapentadol designed for managing severe and moderate to severe pain, respectively. Collegium focuses on addressing the challenges related to the non-medical use of prescription drugs by emphasizing tamper-resistant features and innovative delivery systems in its product portfolio. Founded in 2002 and based in Stoughton, Massachusetts, the company aims to provide effective pain management solutions while prioritizing patient safety.

Nexidia

Series E in 2006
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.

Athenix

Series C in 2006
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

GlycoFi Inc.

Series C in 2005
GlycoFi is a biotech firm that develops biotherapeutics based on the glycan optimization technology. The firm aims to develop its own pipeline of therapeutic proteins and team with other drug-makers to develop products. GlycoFi has developed a protein manufacturing process using yeast-based glycolysation where the resulting proteins can be used in drug development. GlycoFi was incorporated in 2000 and is based in Lebanon, New Hampshire. As of June 6, 2006, GlycoFi, Inc. operates as a subsidiary of Merck & Co. Inc.

Nexidia

Series D in 2005
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.

Novalar Pharmaceuticals

Series C in 2005
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Netifice Communications

Venture Round in 2005
Netifice Communications is redefining how Managed Service Providers deliver secure IP data and voice communication services.

Arthrosurface

Venture Round in 2005
Arthrosurface, Inc. operates as an orthopedic medical device company that designs and manufactures minimally invasive joint resurfacing systems. The company offers surface implant curvatures for knee, shoulder and wrist, hip, foot and ankle, and toe. Its surface implant curvatures are designed to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease. The company serves patients and surgeons through a network of sales representatives or distributors in the United States and internationally. Arthrosurface, Inc. was incorporated in 2001 and is based in Franklin, Massachusetts. As of February 3, 2020, Arthrosurface, Inc. operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

FastChannel Network

Venture Round in 2005
FastChannel provides innovative, technology-based solutions to help advertisers and agencies work faster, smarter and more competitively. Through the FastChannel Intelligence and Control platform customers leverage an integrated suite of intelligence and workflow tools designed specifically for the advertising industry—competitor tracking, creative and production resourcing, broadcast verification, and digital asset management. The company also features an online media distribution network, with more than 5,000 advertisers and agencies, and 21,000 online broadcast and publishing destinations.

SensorLogic

Series A in 2004
SensorLogic specializes in machine-to-machine (M2M) application hosting and offers a platform-as-a-service (PaaS) that delivers customizable M2M solutions integrated with a nationwide GSM/GPRS network. Through its XpressIQ Service Suite, SensorLogic provides customers with ready-to-use applications for GPS tracking, asset monitoring, and control, along with additional network services. By focusing on cloud-based M2M applications, SensorLogic enables businesses to efficiently manage and optimize their operations through advanced technology solutions.

Rejuvenon

Series B in 2004
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.

Tropos Networks

Series D in 2004
Tropos Networks is a supplier of systems used to build metro-scale Wi-Fi networks. Tropos' products enable network operators, service providers and government departments to provide ubiquitous, metro-scale, broadband, wireless data coverage for users in any locale. Tropos' solution creates a truly wireless network, free from the requirement of per node wired connectivity associated with Wi-Fi hot spot deployments using access points. Tropos' products enable larger coverage areas, decreased installation costs and decreased operational costs.

Continuum Photonics

Series C in 2004
Continuum's mission is to provide optical networking equipment manufacturers with strategic subsystems that enable higher bandwidth products and associated revenue-generating services at a substantially lower cost. As a first step, Continuum Photonics is developing a radically different, operationally and economically beneficial photonic switch that will solve many of the problems associated with delivering and managing optically-transported bandwidth.

CombinatoRx

Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

Zalicus

Series D in 2004
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

Athenix

Series B in 2004
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

Infotrieve

Series B in 2004
Information management company providing consultation and business service solutions for information centers

Galt Associates, Inc

Venture Round in 2004
Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports more than 70 pharmaceutical, medical device and biotechnology companies, as well as contract research organizations (CRO) and research institutions located throughout the U.S. and Europe

Novalar Pharmaceuticals

Series B in 2003
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

MedAptus

Venture Round in 2003
MedAptus, Inc. specializes in developing clinical workforce and workflow solutions that enhance charge capture and operational management for healthcare providers. The company offers a variety of products tailored to different healthcare settings, including Pro Charge Capture for hospitalist groups and multi-specialty clinics, and various editions designed for specific needs, such as the Inpatient Edition for hospitalists and the Facility Edition for outpatient clinics. These solutions aim to streamline patient management tasks, improve charge capture efficiency, and reduce administrative burdens. Additionally, MedAptus provides cloud-based tools like Assign for Rounding Providers, which optimizes daily patient assignments, and MedAptus Collaborate, which facilitates secure communication among care teams. The company serves a diverse clientele, including hospitals, health systems, group practices, and academic medical centers. Founded in 1999 and based in Boston, Massachusetts, MedAptus operates as a subsidiary of Volaris Group Inc.

CardioMEMS

Series B in 2003
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Protein Forest

Series A in 2003
Protein Forest, Inc. develops, manufactures and markets instruments, consumables, and software products to scientists for protein separation and bioanalysis applications in the United States and internationally. The company offers digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing for mass spec analysis and western blotting. Its solutions include dPC fractionator, which runs separate samples under controlled temperature, voltage, and mixing; dPC fractionator workflow, which integrates existing mass spectroscopy workflows; dPC PlugHarvestor, which allows users to select and group a set of pH gel plugs into a tube or a microplate; and bioinformatics software products. The company serves scientists in life science, drug discovery, pharmaceutical, biotech, and diagnostic industries. Protein Forest, Inc. was founded in 2002 and is based in Lexington, Massachusetts.

Collegium Pharmaceutical

Series A in 2003
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating patients suffering from pain, particularly in relation to opioid medications. The company utilizes its proprietary DETERx platform technology, which enhances the safety and extended-release properties of medications while minimizing the risk of misuse through methods such as chewing, crushing, and injecting. Among its key offerings is Xtampza ER, an abuse-deterrent, extended-release formulation of oxycodone, alongside Nucynta ER and Nucynta IR, which are formulations of tapentadol designed for managing severe and moderate to severe pain, respectively. Collegium focuses on addressing the challenges related to the non-medical use of prescription drugs by emphasizing tamper-resistant features and innovative delivery systems in its product portfolio. Founded in 2002 and based in Stoughton, Massachusetts, the company aims to provide effective pain management solutions while prioritizing patient safety.

PHT Corporation

Series E in 2003
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

Arthrosurface

Series B in 2003
Arthrosurface, Inc. operates as an orthopedic medical device company that designs and manufactures minimally invasive joint resurfacing systems. The company offers surface implant curvatures for knee, shoulder and wrist, hip, foot and ankle, and toe. Its surface implant curvatures are designed to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease. The company serves patients and surgeons through a network of sales representatives or distributors in the United States and internationally. Arthrosurface, Inc. was incorporated in 2001 and is based in Franklin, Massachusetts. As of February 3, 2020, Arthrosurface, Inc. operates as a subsidiary of Anika Therapeutics, Inc.
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Entigo

Venture Round in 2003
Entigo specializes in enterprise warranty chain management solutions, providing businesses with tools to streamline warranty processing. Its primary offerings include Entigo Warranty, which facilitates the management of warranty claims, and Entigo Catalyst, designed for strategic assessments of existing warranty operations. The company also offers a range of services such as project management, implementation consulting, and systems integration. These solutions aim to automate the registration and claims process, reduce error rates, and enhance analytics for informed decision-making, ultimately improving product quality and minimizing warranty costs. Entigo's systems are tailored to meet the needs of Fortune 500 manufacturers across various sectors, including automotive, aerospace, and industrial equipment. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to optimizing warranty processes and ensuring seamless integration with warranty chain partners.

Tropos Networks

Series C in 2003
Tropos Networks is a supplier of systems used to build metro-scale Wi-Fi networks. Tropos' products enable network operators, service providers and government departments to provide ubiquitous, metro-scale, broadband, wireless data coverage for users in any locale. Tropos' solution creates a truly wireless network, free from the requirement of per node wired connectivity associated with Wi-Fi hot spot deployments using access points. Tropos' products enable larger coverage areas, decreased installation costs and decreased operational costs.

NuVox

Private Equity Round in 2002
Windstream Communications provides voice and data network communications, and managed services to businesses in the United States.

Novalar Pharmaceuticals

Series A in 2002
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Nexidia

Series B in 2002
Nexidia Inc. specializes in developing dialogue and audio analysis technologies designed to optimize audio and video media. The company's product offerings include Nexidia Interaction Analytics for analyzing multichannel contact center interactions, Nexidia Capture for call recording and storage, and real-time monitoring solutions such as Nexidia Scan and Agent Assist. Additionally, Nexidia provides tools like Dialogue Search for content discovery, QC for automating closed caption verification, and Comply for video program automation. Its offerings extend to Audio Discovery OnDemand for sound recording analysis, and various search solutions for managing large volumes of audio and video content. Nexidia also delivers consulting, training, and support services across multiple industries, including communications, healthcare, and media. Founded in 2000 and based in Atlanta, Georgia, Nexidia was previously known as Fast-Talk Communications, Inc. and became a subsidiary of NICE Systems Ltd. in 2016.

TechSmart.com

Venture Round in 2002
TechSmart.com (the "Company"), formed in April 1997 under the name Linx Technologies, offers original equipment manufacturers, lessors, retailers, e-tailers and large corporations a web-based asset recovery solution ("Assets into Money") to effectively manage and resell their returned, refreshed, off-lease and overstock office technology assets ("recovered assets"). These businesses, which They call SmartPartners, send their technology assets to TechSmart.com's processing facilities where the assets are audited, tested, cleaned, packaged and remarketed through the Company's web site. Historically, businesses with recovered assets operated an inefficient in-house program in conjunction with a multi-tiered chain of "mom and pop" refurbishers, brokers, resellers and service providers. Because recovered asset management is not a core competency of these asset owners, they incurred excessive processing costs and achieved sales far below fair market value.

WebCT

Venture Round in 2002
WebCT, Inc. is the world's leading provider of e-Learning solutions for higher education. WebCT began with an educator's dream for his students: a flexible, integrated environment where he could use the latest technology to foster inquiry, encourage discourse and inspire collaboration. Today, our mission is to help institutions deliver on their commitment to educational excellence with enterprise-wide learning management solutions which integrate the richest and most flexible pedagogical tools with existing campus infrastructure. In support of that mission, we have created a family of products and services that are being used to transform the educational experience of students around the world.

PhotonEx

Series C in 2001
PhotonEx is a prominent event in the UK, focusing on photonics and light technologies. It serves as a platform to showcase innovations and advancements in this field, bringing together industry experts, researchers, and businesses to discuss and explore the latest developments. In addition to organizing this event, PhotonEx is involved in the development of smart photonic systems aimed at enhancing public telecommunications networks. By integrating cutting-edge photonic technologies, the company aims to improve the efficiency and performance of telecommunications infrastructure. Through its initiatives, PhotonEx plays a crucial role in promoting the growth and application of photonics in various sectors.

Athenix

Series A in 2001
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

Verio

Venture Round in 2001
Verio Inc. is a provider of online business solutions, primarily catering to small and medium-sized businesses. The company offers a range of services, including shared website hosting, domain name registration, VPS hosting, and website design. Additionally, Verio provides SSL certificates, Microsoft Exchange services, and various marketing solutions such as search engine optimization and email marketing. It operates through a global network of channel partners, enabling access to its services in over 200 countries. Verio also emphasizes customer support, offering assistance via phone, email, and online chat. Formerly known as WorldNet Access, Inc., Verio was established in 1996 and is based in Orem, Utah, with data centers in Boston, Massachusetts. It operates as a subsidiary of NTT Communications, leveraging their infrastructure to deliver reliable and scalable internet services.

iParty

Venture Round in 2001
PartyCity offers consumers a supply chain that provides store locations, company history, press releases, and stock quotes.

MedAptus

Series B in 2000
MedAptus, Inc. specializes in developing clinical workforce and workflow solutions that enhance charge capture and operational management for healthcare providers. The company offers a variety of products tailored to different healthcare settings, including Pro Charge Capture for hospitalist groups and multi-specialty clinics, and various editions designed for specific needs, such as the Inpatient Edition for hospitalists and the Facility Edition for outpatient clinics. These solutions aim to streamline patient management tasks, improve charge capture efficiency, and reduce administrative burdens. Additionally, MedAptus provides cloud-based tools like Assign for Rounding Providers, which optimizes daily patient assignments, and MedAptus Collaborate, which facilitates secure communication among care teams. The company serves a diverse clientele, including hospitals, health systems, group practices, and academic medical centers. Founded in 1999 and based in Boston, Massachusetts, MedAptus operates as a subsidiary of Volaris Group Inc.

Sensitech

Venture Round in 2000
Sensitech® is a world leader in supply chain visibility. Their innovative monitoring products and services help to maintain the quality, integrity and security of their customers' valuable products at every step in their journey, all around the world. For more than 25 years, leading companies in the food, pharmaceutical, industrial, consumer goods, and other industries have relied on Sensitech to help protect their products—and their bottom lines.

Geyser Networks

Venture Round in 2000
As of October 12, 2001, Geyser Networks, Inc. went out of business. The company provides multi service optical solutions for the next generation optical networks. It designs and markets high-performance networking appliances including switching and routing systems. The company has developed the FlexBand™ technology, which integrates n x VT1.5 virtual concatenation, Dynamic Bandwidth Allocation (DBA) and traffic management to generate multiple TDM-like pipes for various applications. Geyser's product using this technology include: Geyser OSM 4800™ (Optical Service Manager) combines critical network elements (i.e. DWDM, MPLS Router, Ethernet Switch, IAD, etc.) into one metropolitan area networking platform; and Geyser Networks MetroView™ Network Manager System (NMS) providing a customer services management system for optical networks, linking business-level software for billing, alarm correlation, and northbound functionalities. The company was founded in 1999 and is based in Sunnyvale, California.

PHT Corporation

Series C in 2000
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

Totality

Series B in 2000
Totality specializes in application and infrastructure management services tailored for large-scale e-commerce websites that demand mass customization. The company addresses essential needs of its clients by offering solutions that ensure high performance and visibility into business processes. Through its focused service level agreements, Totality aims to deliver guaranteed business outcomes, effectively supporting the operational requirements of its customers.

InfoImage

Venture Round in 2000
InfoImage Inc. provides software solutions that automate business processes. The Company offers a variety of software tools and consulting services for use in streamlining office processes. InfoImage's products and services utilize object technology, groupware, intranets, and the Internet.

V-Span

Venture Round in 2000
V-SPAN is the leading video-oriented collaboration and conferencing services provider. Our portfolio includes video, audio, web and streaming for the enterprise and channel markets. Through our online self-service solutions, experienced full-service call centers and diversified global networks, V-SPAN enables its customers to conduct effective electronic meetings, events and training.

New World Communications

Venture Round in 2000
NewWorld Communications is an information technology and communications consulting firm that enables midsize businesses and enterprises to implement network, mobility, and cloud solutions. It also offers contract negotiation, strategic planning and design, project management and implementation, and support services. NewWorld Communications was acquired by Nextel Communications in January 2003. NewWorld Communications was founded in 1999 and is based in Atlanta, Georgia.

P&H Solutions

Venture Round in 2000
P&H Solutions Inc. was acquired by ACI Worldwide, Inc. P&H Solutions, Inc. provides Web-based corporate cash management solution, Web Cash Manager Suite in North America. It also offers outsourcing, project management, training, sales and marketing support, technical support, and conversion services. The company serves financial institutions, credit unions, and regional financial institutions. The company was formerly known as Politzer & Haney, Inc. and changed its name to P&H Solutions, Inc. in November 2004. The company was founded in 1983 and is headquartered in Newton, Massachusetts. P&H Solutions, Inc.

Tavolo

Venture Round in 2000
Tavolo offers an online store that enables its users to find and buy products related to cooking. Tavolo was acquired by OurHouse in December 2000. It is based in San Rafael, California.

EC Cubed

Venture Round in 2000
EC Cubed, recognized by ComputerWorld as one of the "Top 100 Emerging Companies to Watch in 2000," is revolutionizing the development and delivery of dynamic B2B e-Commerce solutions. We enable true B2B e-Commerce -- the seamless interconnection of externalized business processes and technologies with an ever-changing landscape of customers, suppliers, and trading partners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.